The ACR’s new RISE Registry, set for 2026, will be a modern productivity tool with new analytics, easy EHR connection & robust research data.
Latest News
ACR Advocacy Update 2025, Federal & State
ACR representatives outlined its 2025 legislative priorities, including fixing the MPFS, reforming prior authorization & protecting telehealth reimbursement.
As Understanding of Long COVID Deepens, the Search for Therapies Continues
Experts discussed causes of long COVID & potential therapies at this ACR Convergence 2025 session.
No Longer as Vexing: The Role of Somatic Mutations in Rheumatic Diseases
At this ACR Convergence 2025 session, two experts discussed VEXAS & the role that genetic sequencing should play in the practice of a rheumatologist.
Collaboration Is Key to Oral Health in Scleroderma & Sjögren’s Disease
At this ACR Convergence 2025 session, experts discussed the oral manifestations of scleroderma & Sjögren’s disease & the importance of dentists & rheumatologists working together.
The Microbiome’s Impact on Rheumatoid Arthritis & Drug Response
The gut microbiome may trigger RA & predict methotrexate response. ACR Convergence 2025 experts discuss pathogenesis & drug efficacy.
New Rheumatoid Arthritis Risk Stratification Criteria Released
New EULAR/ACR criteria help stratify RA risk in patients with arthralgia. Learn how these criteria guide earlier interventions & improve trial rigor.
Rheuminations: Address Ableism, Improve Care for All Patients
Ableism—discrimination against those with disabilities—distorts diagnostic reasoning & erodes patient trust. How can rheumatologists address this bias?
President’s Corner: Reflections on the ACR’s 2025
Dr. Langford’s final column reflects on 2025’s advocacy, challenges & member teamwork. Click through to read the outgoing ACR president’s parting thoughts.
